Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bionano Genomics Inc
(NQ:
BNGO
)
0.5259
+0.0084 (+1.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bionano Genomics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript
August 08, 2024
BNGO earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
August 07, 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Quantum AI Stocks That Could Redefine Computing
July 16, 2024
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Sorry Healthcare Stocks to Sell in May While You Still Can
May 28, 2024
Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell.
Via
InvestorPlace
The 3 Best Healthcare Stocks to Buy in May 2024
May 10, 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
Via
InvestorPlace
Earnings Outlook For Bionano Genomics
March 04, 2024
Via
Benzinga
How Is The Market Feeling About Bionano Genomics?
January 26, 2024
Via
Benzinga
Bionano Genomics: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
A Preview Of Bionano Genomics's Earnings
November 07, 2023
Via
Benzinga
What's Going On With Bionano Genomics Stock?
August 07, 2023
Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday.
Via
Benzinga
BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
May 08, 2024
BNGO earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
3 Contrarian Investments to Make Now for Massive Upside Potential
April 25, 2024
A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive.
Via
InvestorPlace
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
March 06, 2024
BNGO earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
March 05, 2024
BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
February 07, 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks.
Via
InvestorPlace
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
January 17, 2024
These excellent contrarian stock picks are well-positioned to benefit from huge trends and are likely to be very profitable for investors.
Via
InvestorPlace
LeddarTech Appoints Chris Stewart as Chief Financial Officer
November 15, 2023
From
LeddarTech inc.
Via
GlobeNewswire
3 Stocks That Are Poised to Generate Outsized Returns
November 10, 2023
The Street is greatly underestimating the potential of these three names, making them wonderful stocks to buy for big returns.
Via
InvestorPlace
Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript
November 08, 2023
BNGO earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
3 Deeply Undervalued Growth Stocks
October 27, 2023
As in 2022, the current downturn of stocks appears to be way overdone, making this a good time to buy undervalued growth stocks.
Via
InvestorPlace
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
September 26, 2023
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.
Via
InvestorPlace
The 3 Best High-Risk, High-Reward Stocks to Buy Now: September 2023
September 11, 2023
The stock market's multiple challenges should dissipate soon, making now a good time to buy high-risk, high-reward stocks.
Via
InvestorPlace
7 F-Rated Meme Stocks to Avoid Like the Plague
September 04, 2023
Meme stocks are rarely a good idea. These popular meme stocks should be avoided at all costs – no matter what you may see on social media.
Via
InvestorPlace
These Are the ONLY 3 Meme Stocks to Consider in August 2023
August 28, 2023
While all meme stocks have been crushed, there are still a few meme stocks that look poised to eventually succeed.
Via
InvestorPlace
Why Bionano Genomics Stock Tanked Today
August 14, 2023
A CFO departure shines a light on some of the company's recent struggles.
Via
The Motley Fool
3 Top Short Squeeze Stocks for August 2023
August 10, 2023
With the bears pouncing on many strong growth names, many excellent short squeeze opportunities have been created.
Via
InvestorPlace
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript
August 09, 2023
BNGO earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
DKNG Stock Alert: Wells Fargo Just Upgraded DraftKings
August 07, 2023
DraftKings (DKNG) stock is on the move Monday after getting an upgrade and new price target from Wells Fargo analyst Daniel Politzer.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.